180 related articles for article (PubMed ID: 8540311)
1. Serum pepsinogen values as possible markers for evaluating the possibility of peptic ulcer recurrence under H2-blocker half-dose maintenance therapy.
Matsushima M; Miki K; Ichinose M; Kakei N; Yahagi N; Kido M; Shimizu Y; Ishihama S; Tsukada S; Kurokawa K
Adv Exp Med Biol; 1995; 362():131-7. PubMed ID: 8540311
[No Abstract] [Full Text] [Related]
2. Helicobacter pylori infection and serum pepsinogen I concentration in peptic ulcer patients: effect of bacterial eradication.
Park SM; Park J; Chang SK; Yoo BC; Kim HJ
Korean J Intern Med; 1996 Jan; 11(1):1-8. PubMed ID: 8882471
[TBL] [Abstract][Full Text] [Related]
3. Increased serum pepsinogen I and recurrence of duodenal ulcer.
Sumii K; Inbe A; Uemura N; Kimura M; Haruma K; Yoshihara M; Teshima H; Kajiyama G; Miyoshi A
Scand J Gastroenterol; 1989 Dec; 24(10):1200-4. PubMed ID: 2574906
[TBL] [Abstract][Full Text] [Related]
4. [Peptic ulcer: current therapy].
Pieragnoli E
G Clin Med; 1987 Apr; 68(4):197-209. PubMed ID: 2886387
[No Abstract] [Full Text] [Related]
5. Serum group I pepsinogens by radioimmunoassay in control subjects and patients with peptic ulcer.
Samloff IM; Liebman WM; Panitch NM
Gastroenterology; 1975 Jul; 69(1):83-90. PubMed ID: 1150038
[TBL] [Abstract][Full Text] [Related]
6. [The medical therapy of peptic ulcer. The state of the art].
Perroni GB; De Matteis G; Pellizzeri F; Cassone A; Malara F
Minerva Chir; 1992 Apr; 47(7):607-12. PubMed ID: 1350332
[No Abstract] [Full Text] [Related]
7. Pepsinogen Group I radioimmunoassay and total serum pepsinogen colorimetric determination: a comparative study in normal subjects and in peptic ulcer patients.
Plebani M; Di Mario F; Vianello F; Giordano A; Masiero M; Lazzaretto M; Farini R; Ceriotti G; Naccarato R
Clin Biochem; 1983 Feb; 16(1):20-2. PubMed ID: 6861334
[TBL] [Abstract][Full Text] [Related]
8. [Therapy of peptic ulcer. H2 receptor blockers].
Domschke W
Verh Dtsch Ges Inn Med; 1988; 94():272-5. PubMed ID: 2905101
[No Abstract] [Full Text] [Related]
9. [Clinical, secretory, radiological and endoscopic evolution of patients with gastroduodenal ulcer treated with Ulcosilvanil, as compared with those treated with histamine H2 receptor antagonists].
Contraşiu P; Calinici V
Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Med Interna; 1980; 32(4):359-63. PubMed ID: 6113650
[No Abstract] [Full Text] [Related]
10. [Current aspects of course treatment and secondary prevention of peptic ulcer].
Ryss ES
Klin Med (Mosk); 1990 Apr; 68(4):134-42. PubMed ID: 1973467
[No Abstract] [Full Text] [Related]
11. [A clinico-endoscopic study on cicatrization of lesions and prevention of recurrences in patients with liver cirrhosis and peptic ulcer].
Di Mario F; Gottardello L; Burra P; Salvagnini M; Dalrì L; Leandro G; Contento F; Torri A; Naccarato R
G Clin Med; 1990 Apr; 71(4):259-62, 265-6. PubMed ID: 1973392
[TBL] [Abstract][Full Text] [Related]
12. [Anti-ulcer drugs. Indications in adults. French Agency of the Safety of Health Products].
Presse Med; 2000 Jan; 29(2):86-94. PubMed ID: 10682037
[No Abstract] [Full Text] [Related]
13. [New therapy of peptic ulcer].
Harada T
Nihon Naika Gakkai Zasshi; 1995 Mar; 84(3):386-9. PubMed ID: 7751774
[No Abstract] [Full Text] [Related]
14. Time, change and peptic ulcer disease in Rotherham, UK.
Bardhan KD; Royston C
Dig Liver Dis; 2008 Jul; 40(7):540-6. PubMed ID: 18407812
[TBL] [Abstract][Full Text] [Related]
15. [H2 blockers in the treatment of bleeding gastroduodenal ulcers].
Nikiforov PA; Bazarova MA; Nikitina SA; Osin VL; Shugurov VA
Khirurgiia (Mosk); 2001; (10):49-50. PubMed ID: 11763821
[No Abstract] [Full Text] [Related]
16. A 35-year-old man with epigastric pain.
Glickman R
JAMA; 1995 Aug; 274(6):495-500. PubMed ID: 7629961
[No Abstract] [Full Text] [Related]
17. Clinical studies on the use of roxatidine acetate for the treatment of peptic ulcer in Japan.
Inoue M
Drugs; 1988; 35 Suppl 3():114-9. PubMed ID: 2905239
[TBL] [Abstract][Full Text] [Related]
18. Future trends in the management of peptic ulcer disease.
Misiewicz JJ
Scand J Gastroenterol Suppl; 1988; 146():175-84. PubMed ID: 2906462
[TBL] [Abstract][Full Text] [Related]
19. [Histamine H2-receptor antagonists as new anti-ulcer agents].
Takemoto T
Nihon Rinsho; 1984 Jan; 42(1):103-13. PubMed ID: 6143835
[No Abstract] [Full Text] [Related]
20. [Concerning the discussion article by I. A. Morozov "Choice of the gastroenterologist"].
Gorshkov VA
Klin Med (Mosk); 2002; 80(9):66-70. PubMed ID: 12416232
[No Abstract] [Full Text] [Related]
[Next] [New Search]
